| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |